JW (Cayman) Therapeutics Co. Ltd (2126.HK) HKSE

6.03

+0.14(+2.38%)

Updated at August 18 04:09PM

Currency In HKD

Valuation

Market Cap497.26M
Enterprise Value162.29M
P/E Ratio-3.88
PEG Ratio-0.66
Price/Sales Ratio14.19
Price/Book Ratio1.96
Enterprise/Revenue12.08
Enterprise/EBITDA-5.01

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-3.73
Operating Margin0

Management Effectiveness

Return On Assets-0.35
Return On Equity-0.45

Income Statement

Revenue158.22M
Revenue/Share0.38
Gross Profit77.32M
EBITDA-381.58M
Net Income-590.62M
Diluted EPS-1.43

Balance Sheet

Total Cash757.38M
Total Cash/Share1.83
Total Debt422.4M
Total Debt/Equity0.36
Current Ratio1.74
Book Value Per Share2.82

Price History

52-Week Change324.65
52-Week High6.44
52-Week Low1.19
Moving Average 50 Days3.56
Moving Average 200 Days2.08

Statistics

Average Volume4.71M
Shares Outstanding405.53M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A